EXETER, N.H.--(BUSINESS WIRE)--Feb. 27, 2006--Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical and drug delivery company, today announced that it has received twelve marketing approvals in Spain for various dosage forms of citalopram (generic version of Celexa(R)), finasteride (generic version of Proscar(R)) and pravastatin (generic version of Pravachol(R)).
